Mycoplasma Pneumonia

RESFLOR GOLD (florfenicol and flunixin meglumine) is a simple bovine respiratory disease (BRD) treatment strategy. It involves a combination of two therapies in one dose: the powerful antibiotic florfenicol to kill or inhibit the disease-causing bacteria Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and, the fast-acting non-steroidal anti-inflammatory drug (NSAID) flunixin meglumine to reduce BRD-associated fever.

An aid in the prevention of pneumonia caused by Mycoplasma hyopneumoniae. Convenient one- or two-dose options (2 mL once or 1 mL twice, see complete label instructions) for one-dose and two-dose programs (see complete label instructions). Unique patented dual-emulsion adjuvant. Up to six months DOI after one 2 mL injection. Solid measurable serologic response. Second 1 mL injection given two to three weeks after first 1 mL injection administered at week three. (Second injection not required if 2 mL injection is given at week three.)